Literature DB >> 22093284

Characterization of clinical response in patients with vitiligo undergoing autologous epidermal punch grafting.

Hattie Jill Feetham1, Joanna L Chan, Amit G Pandya.   

Abstract

BACKGROUND: Punch grafting is a well-established treatment for vitiligo, but predictive factors for outcomes are not well established.
OBJECTIVE: To determine the characteristics of responses to punch grafting performed in patients with vitiligo. METHODS AND MATERIALS: Retrospective, single-center chart review. Response rates were assessed using photographs taken before and after grafting using a 1.5-mm punch instrument. Effectiveness of repigmentation was assessed using the following scale: worse, no improvement, 0% to 25% improvement, 25% to 50% improvement, 50% to 75% improvement, and 75% to 100% improvement. Repigmentation rates were correlated with patient demographics.
RESULTS: Thirty-seven charts were reviewed, from which data were available from 30 patients. The total number grafts was 606 in 44 transplanted areas; 87% (530/606) of the transplants survived, and 26 of the 30 (87%) patients achieved some degree of repigmentation. Patients younger than 20 achieved the greatest average improvement in repigmentation (mean 61%), whereas those aged 60 and older showed the least improvement (mean 38%). Punch grafting of the neck and trunk achieved the greatest repigmentation, with 65% and 63% average improvement, respectively. Acral sites and skin overlying joints improved the least.
CONCLUSION: Punch grafting is successful in most patients with vitiligo, with an 87% graft survival rate, but the rates of repigmentation vary depending on clinical characteristics.
© 2011 by the American Society for Dermatologic Surgery, Inc. Published by Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2011        PMID: 22093284     DOI: 10.1111/j.1524-4725.2011.02171.x

Source DB:  PubMed          Journal:  Dermatol Surg        ISSN: 1076-0512            Impact factor:   3.398


  3 in total

Review 1.  Advances in Vitiligo: An Update on Medical and Surgical Treatments.

Authors:  Alexander B Dillon; Andrew Sideris; Ali Hadi; Nada Elbuluk
Journal:  J Clin Aesthet Dermatol       Date:  2017-01-01

Review 2.  Recent advances in understanding vitiligo.

Authors:  Prashiela Manga; Nada Elbuluk; Seth J Orlow
Journal:  F1000Res       Date:  2016-09-06

3.  Combination therapy of orally administered glycyrrhizin and UVB improved active-stage generalized vitiligo.

Authors:  K H Mou; D Han; W L Liu; P Li
Journal:  Braz J Med Biol Res       Date:  2016-07-25       Impact factor: 2.590

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.